Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Diaz A. Quantitative sensory testing: a good tool to identify subclinical neuropathy in ATTRV30M amyloidosis patients? Amyloid.

Investigación y Educación

"Background Quantitative sensory testing (QST) has been one of the neurophysiological tools used for follow-up and disease progression assessment in ATTRv amyloidosis. We aimed to detect the utility of QST in identifying subclinical neuropathic involvement in ATTRV30M amyloidosis carriers.

Conclusions QST, in particular CDT, HP 5 and HP 0.5 modalities, seems a good tool to identify subclinical neuropathy in ATTRv amyloidosis carriers, with CDT showing a higher sensitivity to detect and early neuropathic involvement."

Read full article

Artículos que te pueden interesar

Neurología

"Frequency of NMOSD misdiagnosis in a cohort from Latin America: Impact and evaluation of different contributors. Mult Scler. 2022 Dec"

Diciembre 1, 2022

Leer más

Neurología

Clinical, pathological and genetic characteristics of Perry disease-new cases and literature review. Eur J Neurol.

Agosto 26, 2021

Leer más

Neurología

Structural Protein Effects Underpinning Cognitive Developmental Delay of the PURA p.Phe233del Mutation Modelled by Artificial Intelligence and the Hybrid Quantum Mechanics-Molecular Mechanics Framework. Brain Sci. 2022 Jun

Junio 30, 2022

Leer más